CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Paul LaViolette

Chief Executive Officer and Co-Chairman of the Board, Pulse Biosciences, Inc.

Search every verified Paul LaViolette interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Paul LaViolette, CEO and Co-Chairman of Pulse Biosciences, has been active in public discussions about the medical technology industry throughout 2025. In a November 2025 fireside chat, he described the medtech innovation ecosystem as "more fragile" than biotech, citing limited capital sources and a mismatch between where funding is concentrated and where exits occur. He advised entrepreneurs to build companies for realistic exit outcomes, noting that most medtech exits occur at $200 million or less. In a June 2025 podcast, LaViolette discussed his decision to lead Pulse Biosciences, describing it as a "very innovative platform company" in the pulsed field ablation (PFA) space. He said the company is pursuing non-cardiovascular indications, including a soft tissue ablation treatment for benign thyroid nodules as an alternative to surgical removal. LaViolette also participated in an April 2025 panel on CEO transitions, where he drew on his governance experience to discuss challenges boards face in evaluating leadership. He acknowledged that boards can be insulated from day-to-day operations and shared that, in one past situation, he and fellow board members "kept hoping" a CEO performing at 95% could reach 100%, which he characterized as a mistake. He advised against delaying CEO changes when a company has only four months of cash runway. In a 2021 fireside chat, he expressed optimism about the medtech industry's recovery from the pandemic and discussed trends in SPACs and remote patient monitoring reimbursement.

Recent appearances

  • Leading Innovation into the Future: A Fireside Chat with Paul LaViolette

    November 10, 2025 · 📺 MassMEDIC

    In this candid fireside chat, Bryan Gilpin, President of Suntra MedTech Solutions, joins Paul LaViolette, Co-Chairman and CEO of Pulse Biosciences (NASDAQ: PLSE), Managing Partner at SV Health Investors, and former COO of Boston Scientific, to explore the state of medtech innovation—where we're headed, and how investors, strategics, entrepreneurs, and service providers must collaborate to build the future together. Framed as a point–counterpoint discussion, the conversation will reveal real-world lessons and actionable insights drawn from consulting, investing, and managerial perspectives—spa…

    Watch on YouTube ↗

  • Boston Sci, SV, now Pulse Biosciences – Why Paul LaViolette loves...

    June 20, 2025 · 📺 DeviceTalks

    In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Paul LaViolette, president and CEO of Pulse Biosciences. LaViolette takes us back to the early days of the medical device industry and shares how close collaboration with interventionalists helped shape today’s MedTech landscape. We dive into one of the biggest deals in MedTech history — Boston Scientific’s acquisition of Guidant — and why it was crucial for the company’s survival despite its rocky road. LaViolette also explains why investing in MedTech has never been more challenging and what drew him to lead Pulse…

    Watch on YouTube ↗

  • Navigating CEO Transitions — When, Why, and How to Make a Change | LSI USA '25

    April 24, 2025 · 📺 LSI - Life Science Intelligence™

    This panel took place at LSI USA '25 Emerging Medtech Summit in Dana Point, CA. Industry leaders from Gilde Healthcare, THINK Surgical, SV Health Investors, and moderator David Krahe from RRA discuss critical considerations and best practices for successfully managing CEO transitions in medtech companies. This panel featured: David Krahe — RRA Mika Nishimura — Gilde Healthcare Stuart Simpson — THINK Surgical Paul LaViolette — Pulse Biosciences Our Event Schedule: LSI Asia '25 (Singapore) June 10th - 13th, 2025 At The Ritz-Carlton® Millenia Singapore LSI Europe '25 (London) September 7th -…

    Watch on YouTube ↗

  • Fireside Chat - Conversation With a Medtech Visionary

    June 28, 2021 · 📺 LSI - Life Science Intelligence™

    #LSI2021 kicked off with the Fireside Chat - Conversation With a Medtech Visionary featured Scott Pantel & Paul Laviolette. In this conversation, we'll tap into the experiences, wisdom and projections of medtech mogul, Paul LaViolette. We'll learn what Paul and his partners are up to with their new Medtech Convergence Fund and we'll have some fun talking about stories from the past and opportunities of the future. The #LSIUSA22 Emerging Medtech Summit will feature medtech start-ups that are raising capital and seeking strategic partners. This event is scheduled for March 15-18, 2022 at the…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →